|
Empyema, Pleural
|
C01.748.265 |
|
|
Hyperparathyroidism
|
D006961 |
[A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
] |
|
Hyperparathyroidism, Secondary
|
D006962 |
[Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
] |
|
Denitrification
|
G02.607.560.250 |
|
|
Nitrogen Cycle
|
G02.607.560 |
|
|
Raloxifene Hydrochloride
|
D02.455.426.559.389.150.700.900.775 |
|
|
Glutamates
|
D12.125.067.625 |
|
|
Amino Acids, Acidic
|
D12.125.067 |
|
|
Analytic Hierarchy Process
|
L01.313.500.750.190.095 |
|
|
Sodium-Glucose Transporter 2 Inhibitors
|
D27.505.519.936 |
|
|
Shoulder Impingement Syndrome
|
C26.803.500 |
|
|
Shoulder Injuries
|
C26.803 |
|
|
Serotonin and Noradrenaline Reuptake Inhibitors
|
D000068760 |
[Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.
] |
|
Rifamycins
|
D03.633.400.811 |
|
|
Mometasone Furoate, Formoterol Fumarate Drug Combination
|
D000068758 |
[A pharmaceutical preparation of mometasone furoate and formoterol fumarate that is used as an inhaled dosage form for the treatment of ASTHMA.
] |
|
Formoterol Fumarate
|
D000068759 |
[An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
] |
|
Alitretinoin
|
D02.455.326.271.665.202.495.818.500.500 |
|
|
Tretinoin
|
D02.455.326.271.665.202.495.818.500 |
|
|
Choristoma
|
C23.300.250 |
|
|
Hypertension, Renovascular
|
D006978 |
[Hypertension due to RENAL ARTERY OBSTRUCTION or compression.
, HYPERTENSION due to renal ISCHEMIA. In 1934, Harry Goldblatt described that hypertension can be produced experimentally by using a clamp to obstruct blood flow to one kidney, the Goldblatt phenomenon.
] |
